UniProt ID | UB2Q2_HUMAN | |
---|---|---|
UniProt AC | Q8WVN8 | |
Protein Name | Ubiquitin-conjugating enzyme E2 Q2 | |
Gene Name | UBE2Q2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 375 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys-48'-linked polyubiquitination.. | |
Protein Sequence | MSVSGLKAELKFLASIFDKNHERFRIVSWKLDELHCQFLVPQQGSPHSLPPPLTLHCNITESYPSSSPIWFVDSEDPNLTSVLERLEDTKNNNLLRQQLKWLICELCSLYNLPKHLDVEMLDQPLPTGQNGTTEEVTSEEEEEEEEMAEDIEDLDHYEMKEEEPISGKKSEDEGIEKENLAILEKIRKTQRQDHLNGAVSGSVQASDRLMKELRDIYRSQSYKTGIYSVELINDSLYDWHVKLQKVDPDSPLHSDLQILKEKEGIEYILLNFSFKDNFPFDPPFVRVVLPVLSGGYVLGGGALCMELLTKQGWSSAYSIESVIMQINATLVKGKARVQFGANKNQYNLARAQQSYNSIVQIHEKNGWYTPPKEDG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSVSGLKAE ------CCCHHHHHH | 25.62 | 22798277 | |
7 | Ubiquitination | -MSVSGLKAELKFLA -CCCHHHHHHHHHHH | 43.25 | 33845483 | |
11 | Ubiquitination | SGLKAELKFLASIFD HHHHHHHHHHHHHHH | 29.82 | 33845483 | |
142 | Ubiquitination | EVTSEEEEEEEEMAE CCCCHHHHHHHHHHH | 74.18 | 29967540 | |
161 | Ubiquitination | LDHYEMKEEEPISGK HCCCCCCCCCCCCCC | 67.30 | 29967540 | |
166 | Phosphorylation | MKEEEPISGKKSEDE CCCCCCCCCCCCCCC | 56.10 | 29759185 | |
170 | Phosphorylation | EPISGKKSEDEGIEK CCCCCCCCCCCCCCH | 54.49 | 25849741 | |
177 | Ubiquitination | SEDEGIEKENLAILE CCCCCCCHHHHHHHH | 50.40 | 29967540 | |
224 | Phosphorylation | YRSQSYKTGIYSVEL HHCCCCCCCEEEEEE | 22.15 | 29978859 | |
227 | Phosphorylation | QSYKTGIYSVELIND CCCCCCEEEEEEECC | 14.17 | 29978859 | |
228 | Phosphorylation | SYKTGIYSVELINDS CCCCCEEEEEEECCC | 13.75 | 29978859 | |
235 | Phosphorylation | SVELINDSLYDWHVK EEEEECCCCEEEEEE | 25.08 | 29978859 | |
237 | Phosphorylation | ELINDSLYDWHVKLQ EEECCCCEEEEEEEE | 22.42 | 29978859 | |
273 | Phosphorylation | EYILLNFSFKDNFPF EEEEEEEECCCCCCC | 30.25 | 24719451 | |
354 | Phosphorylation | NLARAQQSYNSIVQI HHHHHHHHHHHHEEE | 17.75 | 23312004 | |
355 | Phosphorylation | LARAQQSYNSIVQIH HHHHHHHHHHHEEEH | 14.48 | 23312004 | |
357 | Phosphorylation | RAQQSYNSIVQIHEK HHHHHHHHHEEEHHH | 18.86 | 23312004 | |
368 | Phosphorylation | IHEKNGWYTPPKEDG EHHHCCCCCCCCCCC | 15.69 | 30257219 | |
369 | Phosphorylation | HEKNGWYTPPKEDG- HHHCCCCCCCCCCC- | 26.97 | 25159151 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of UB2Q2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UB2Q2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UB2Q2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PCGF2_HUMAN | PCGF2 | physical | 19690564 | |
RN111_HUMAN | RNF111 | physical | 19549727 | |
MYO1C_HUMAN | MYO1C | physical | 16300736 | |
DREB_HUMAN | DBN1 | physical | 16300736 | |
GELS_HUMAN | GSN | physical | 16300736 | |
ANM5_HUMAN | PRMT5 | physical | 16300736 | |
MEP50_HUMAN | WDR77 | physical | 16300736 | |
ARPC2_HUMAN | ARPC2 | physical | 16300736 | |
CAPZB_HUMAN | CAPZB | physical | 16300736 | |
ARPC4_HUMAN | ARPC4 | physical | 16300736 | |
ACTG_HUMAN | ACTG1 | physical | 16300736 | |
UB2Q2_HUMAN | UBE2Q2 | physical | 20061386 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-369, AND MASSSPECTROMETRY. |